List of insiders holdings for RVL Pharmaceuticals plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Burgstahler David F Director 10% Owner |
2023-01-30 17:29:05 | 0 24,763,859 |
24,763,859 | Form 4 |
| 2 | Venkataraman Sriram Director 10% Owner |
2023-01-30 17:28:16 | 0 24,763,859 |
24,763,859 | Form 4 |
| 3 | Avista Capital Partners III GP L.P. ACP III AIV L.P. ACP Holdco (Offshore) L.P. Orbit Co-Invest I LLC Orbit Co-Invest III LLC 10% Owner |
2022-08-09 17:20:21 | 23,730,864 0 |
23,730,864 | Form 13D |
| 4 | Avista Capital Partners III GP L.P. Avista Healthcare Partners GP Ltd. Avista Healthcare Partners L.P. Orbit Co-Invest I LLC Orbit Co-Invest III LLC 10% Owner |
2022-08-09 17:20:21 | 23,730,864 0 |
23,730,864 | Form 13D |
| 5 | Athyrium Opportunities IV Acquisition 2 LP Athyrium Opportunities IV Co-invest 2 LP Athyrium Opportunities Associates IV LP Athyrium Opportunities Associates IV GP LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates IV Co-Invest LLC Ferrell Jeffrey 10% Owner |
2023-11-27 21:24:25 | 14,600,444 0 |
14,600,444 | Form 13D |
| 6 | Harsaul Foundation 10% Owner |
2023-10-23 16:23:52 | 0 4,941,101 |
4,941,101 | Form 4 |
| 7 | MARKISON BRIAN A Chief Executive Officer |
2022-08-09 17:22:00 | 2,976,020 0 |
2,976,020 | Form 4 |
| 8 | Altchem Ltd Orbit Co-Invest A-1 LLC 10% Owner |
2023-11-01 16:27:14 | 1,182,243 0 |
1,182,243 | Form 13D |
| 9 | Schaub James EVP and COO |
2023-05-22 21:21:22 | 524,835 0 |
524,835 | Form 4 |
| 10 | Klein Christopher General Counsel & Secretary |
2023-05-22 21:18:55 | 180,573 0 |
180,573 | Form 4 |
| 11 | Einhorn Andrew J. Chief Financial Officer |
2022-01-26 16:31:55 | 141,473 22,852 |
164,325 | Form 4 |
| 12 | deVries Tina Marie EVP, Research & Development |
2022-05-20 16:28:11 | 136,141 0 |
136,141 | Form 4 |
| 13 | WEISS FRED G Director |
2021-09-03 16:01:30 | 118,466 0 |
118,466 | Form 4 |
| 14 | Lask Alisa Director |
2023-08-14 17:35:04 | 112,557 0 |
112,557 | Form 4 |
| 15 | COWAN GREGORY L Director |
2023-07-11 21:16:24 | 90,055 0 |
90,055 | Form 4 |
| 16 | DeBiasi Michael J. Director |
2023-07-11 21:17:04 | 40,000 0 |
40,000 | Form 4 |
| 17 | Avista Capital Partners III GP L.P. Orbit Co-Invest III LLC Avista Healthcare Partners GP Ltd. Avista Healthcare Partners L.P. 10% Owner |
2023-08-17 17:06:02 | 0 0 |
0 | Form 13D |
| 18 | Avista Healthcare Partners GP Ltd. Avista Healthcare Partners L.P. 10% Owner |
2023-08-17 17:06:02 | 0 0 |
0 | Form 13D |
| 19 | Sielecki Carlos Alberto Director |
2018-10-18 18:38:33 | 0 0 |
0 | Form 3 |
| 20 | DePetris Michael Principal Accounting Officer |
2022-04-22 16:15:32 | 0 0 |
0 | Form 3 |
| 21 | Vergez Juan Augusto Director |
2018-10-18 18:43:31 | 0 0 |
0 | Form 3 |